Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA approves revised product label for Epicel

Feb. 23, 2016

Knight Therapeutics supports Medimetriks' acquisition of OPA-15406

Feb. 18, 2016

Filaggrin inhibits formation of lipid antigens in human skin

Feb. 15, 2016

Otsuka licenses U.S. rights for atopic dermatitis treatment OPA-15406 to Medimetriks

Feb. 9, 2016

FDA grants afamelanotide orphan drug designation for cutaneous porphyria

Feb. 9, 2016

New culture system for seborrheic keratoses allows for the screening of several Akt inhibitors

Feb. 5, 2016

LEO Pharma and arGEN-X select cell line for manufacture of antibody against skin inflammation

Feb. 3, 2016

Ziarco starts phase IIa trial of ZPL-389 in psoriasis

Feb. 2, 2016

FDA accepts BLA submission for brodalumab in moderate to severe plaque psoriasis

Jan. 26, 2016

FDA grants orphan drug designation to mutant KIT inhibitor for mastocytosis

Jan. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...